Testing of blood products for pathogenic agents is an important pillar of blood product safety. Researchers of the Paul-Ehrlich-Institut (PEI) have extended the repository of reference strains for the testing of platelet concentrates (white blood cells) as part of their role as Collaborating Centre for the World Health Organization by ten bacterial strains. That way, 14 bacterial strains are now available for the use in the validation of test systems worldwide. The first four reference strains, too, were developed within the responsibility of the PEI. Vox Sanguinis reports on the extension of the reference materials available in its online edition of 27 September 2017.
The first step in the collection of blood donations alone – the act of piercing through the donor’s skin which is covered with bacteria – involves the potential risk of pathogens entering the blood donation. For this reason, various measures are in place to ascertain that the blood donation is safe throughout the entire blood donation procedure. These include donor screening, effective disinfection of the punctured site of the skin, and the testing of blood products for possible pathogens.
One of the prerequisites for the reliability of the detection methods used in testing for possible pathogens is their validation by means of suitable reference materials (validated test strains). These are comparable with calibration weights of weighing scales. To serve as reliable reference materials, the test strains survive, and must be replicable under the storage conditions determined.
In addition, for a quantitative validation, it is necessary to know the live pathogen count. To guarantee this, a collaborative trial was performed under the supervision of the Paul-Ehrlich-Institut, to which 14 laboratories contributed, and the results of which have now enabled the Paul-Ehrlich-Institut to extend the repository of WHO reference materials by the following bacterial strains:
• Bacillus cereus PEI-B-P-57
• Bacillus thuringiensis PEI-B-P-07
• Enterobacter cloacae PEI-B-P-43
• Morganella morganii PEI-B-P-91
• Proteus mirabilis PEI-B-P-55
• Pseudomonas fluorescens PEI-B-P-77
• Serratia marcescens PEI-B-P-56
• Staphylococcus aureus PEI-B-P-63
• Streptococcus dysgalactiae PEI-B-P-7
• Streptococcus bovis -reklassifiziert als Streptococcus gallolyticus.
As early as 2011 the Paul-Ehrlich-Institut, in collaboration with the “International Society of Blood Transfusion” (ISBT) developed the first bacterial reference panel of four strains (Staphylococcus epidermidis PEI-B-P-06, Klebsiella pneumoniae PEI-B-P-08, Streptococcus pyogenes PEI-B-P-20 und Escherichia coli PEI-B-P-19) in a worldwide collaborative trial. The full genome sequence of these strains is now known and is publicly available  at the American Society for Microbiology (ASM)
All 14 reference materials are cultured by the Paul-Ehrlich-Institut by means of a method especially developed for this purpose and provided as deep-frozen bacterial suspension with a defined pathogen count.
“I am happy that our researchers have made an important contribution to the reliable testing of blood products worldwide through the development and provision of blood products”, said Professor Klaus Cichutek, president of the Paul-Ehrlich-Institut.
WHO Collaborating Centre at the Paul-Ehrlich-Institut
Since 2005, the Paul-Ehrlich-Institut has a WHO Collaborating Centre for the quality assurance of blood products and in vitro diagnostic devices. The work of the WHO Collaborating Centre is multifaceted. The Paul-Ehrlich-Institut initiates and organises standardisation projects for biological reference materials and takes part in collaborative trials worldwide. Members of staff of the Paul-Ehrlich-Institut take an active part in various expert meetings and working parties of the WHO, and, together with other researchers, prepare regulatory documents (WHO Guidelines). Last but not least, the Paul-Ehrlich-Institut regularly provides the WHO in Geneva with experts as part of a secondment
Spindler-Raffel E, Benjamin RJ, McDonald CP, Ramirez-Arcos S, Aplin K, Bekeredjian-Ding I, de Korte D, Gabriel C, Gathof B, Hanschmann KM, Hourfar K, Ingram C, Jacobs MR, Keil SD, Kou Y, Lambrecht B, Marcelis J, Mukhtar Z, Nagumo H, Niekerk T, Rojo J, Marschner S, Satake M, Seltsam A, Seifried E, Sharafat S, Störmer M, Süßner S, Wagner SJ, Yomtovian R for the ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID) Subgroup on Bacteria (2017): Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains.
 Mellmann A, Spindler-Raffel E, Bletz S, Prax M, Bekeredjian-Ding I (2017): Genome Sequences of the First WHO Repository of Platelet Transfusion-Relevant Bacterial Reference Strains.
Genome Announc. 2017 Jul 20;5(29)
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.
Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.
The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).
Abstract of the publication
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522920/ - Full text Version of the Genome Announc publication
Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft
Bacteria as pacemaker for the intestine
22.11.2017 | Christian-Albrechts-Universität zu Kiel
Researchers identify how bacterium survives in oxygen-poor environments
22.11.2017 | Columbia University
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
22.11.2017 | Business and Finance
22.11.2017 | Physics and Astronomy
22.11.2017 | Physics and Astronomy